Distinguished Lecture Series: Dr. James Nataro

  • March 2, 2009

Distinguished Lecture Series: Dr. James Nataro

“Vaccine Development in the Year 2100”

Dr. James Nataro

 

Cambridge University Communications Office:

Vaccines could eventually be developed which could prevent the deaths hundreds of thousands of children a year from diarrhoea, according to an international expert in infectious disease. Dr James P Nataro, a major researcher in vaccine development and global health, is speaking about the future of vaccine development in an open lecture on 2 March organised by the Gates Scholars Council. The lecture, ‘Vaccination in the Year 2100’, will focus on the future of his field, looking forward to the day when vaccines will elicit a more natural form of resistance to infectious diseases.

Dr Nataro’s lab at the University of Maryland focuses particularly on understanding the nature of Ecoli and finding ways of preventing its spread. The World Health Organization says Ecoli accounts for several hundred million cases of diarrhoea and several ten of thousand deaths each year. The lab is also involved in the development of vaccines against potential bioterror agents, especially plague. Dr Nataro is principal investigator on a $5.6m programme funded by the Bill & Melinda Gates Foundation to develop a faster and more precise test to diagnose the causes of diarrhoeal disease in developing countries, which account for at least 18% of deaths of children under five in the world. One of the main problems is identifying the particular pathogens that make children sick. Dr Nataro, who is a professor in the Departments of Pediatrics, Microbiology & Immunology, Biochemistry & Molecular Biology, and Medicine, says current tests for establishing the cause of diarrhoeal disease and therefore the best treatment are “cumbersome” and expensive and so not suited to developing countries. The programme’s goal is to develop mobile technology which allows the causes to be quickly and accurately diagnosed and could eventually lead to the development of suitable vaccines.

The talk took place on March 2, and part of the recording of this lecture is available in mp3 here: http://www.cl.cam.ac.uk/~pb400/DrNataro.mp3

 

Return to the Distinguished Lecture Series Online Calendar and Media Page here.

Latest News

Cambridge event for new book by leading thinkers

Artificial intelligence gets a lot of bad press, but if harnessed correctly has the ability to create jobs and drive growth through enhancing productivity and helping countries level up, according to a new book by some of the world’s leading thinkers. The book, Permacrisis: A Plan to Fix a Fractured World, explores pressing global issues […]

Rainforest carbon credit schemes less effective than thought, claims report

The effectiveness of widely used rainforest carbon credit schemes has been called into question by a new study. The study, Reducing Emissions from Deforestation and Forest Degradation (REDD+) Carbon Crediting,  by the Berkeley Carbon Trading Project is co-authored by Gates Cambridge Scholar Libby Blanchard [2012] and has been making headlines around the world. It brings […]

Gates Cambridge Trust seeks Global Engagement Officer

About us  Gates Cambridge Scholarships are prestigious, highly competitive, full-cost scholarships awarded to outstanding applicants from countries outside the UK to pursue a full-time postgraduate degree in any subject available at the University of Cambridge. Gates Cambridge Scholars become part of a lifelong global community defined by its core value of commitment to improving the […]

How combining clinical data could improve traumatic brain injury outcomes

Researchers, led by a Gates Cambridge Scholar, have integrated all medical data collected from traumatic brain injury (TBI) patients to calculate, for the first time, the personalised contribution of each clinical event to long-term recovery. This international effort marks a step towards patient-centred treatment in the intensive care unit (ICU). Shubhayu Bhattacharyay [2020] is the lead […]